I did not say anything about setting definite deadlines for actions Revive is currently taking. But they ought to be able to enlighten shareholders a little better than just continuing to use the words "soon" or "in the near future" for efforts that Revive has some control over (such as an estimated timeframe for evaluating data on hand). Nobody can say what delays may be created by the FDA once the data or EUA application is submitted.
Please don't "shudder" to think about my future posts based on what I said in my current one. Maybe I should have said I am a little frustrated instead of very frustrated. I dare say that probably most shareholders have some degree of frustration at this point, particularly when every PR statement just seems to repeat what has already been told previously.
News 
Market Data 
Discover 
